InvestorsHub Logo
Followers 31
Posts 1156
Boards Moderated 0
Alias Born 01/05/2010

Re: jainshul post# 7270

Thursday, 12/02/2010 8:26:00 AM

Thursday, December 02, 2010 8:26:00 AM

Post# of 45672
The company is doing what they promised, they are working on rollup stratergy which mean combine 4-5 or more small companies which operate in a certain industry and get them listed on a higher exchange as a single entity with a larger combined market cap, this provides the new public listed entity a lot leverage among its competitors.

Here is a very good case study about rollup strategy http://www.consolidationadvisorsllc.com/casestudy.pdf

Checkout what they said hereunder, once the financing is complete they will acquire another pharmacy distribution company.

JMO

The venue calls for the merging of Xi'an Johnson Pharmaceutical Ltd. with one of our wholly owned subsidiaries, close the financing it has requested, which could be used partially for the potential acquisition of another pharmacy distribution company. Which in turn will help Xi'an Johnson Pharmaceutical continue its quest to become one of the larger publicly traded Chinese pharmaceutical companies in China. Their strategy is similar to another publicly traded pharmaceutical company known as China Jo Jo Drug Stores which is based in the Zheziang Province of China listed under the symbol NASDAQ CJJD.

Subsequent to the merger and financing the company would be registered as a "stand alone" fully reporting public company. We would then distribute shares of Xi'an Johnson Pharmaceutical Ltd. to our shareholder base on a pari passu basis.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AHRO News